Work overview

Section 07 of 08

Ethics declaration

Adjunctive palivizumab with ribavirin for respiratory syncytial virus infection during the early peri-transplant period in adult allogenic hematopoietic stem cell transplant recipients: Case series

Latefah Aleshaiwi, Afrah Alotaibi, Mohsen Alzahrani, Mohammad Bosaeed, Hajar AlQahtani, and Abdulellah Almohaya · 2026

Contents

Section 07 of 08

  1. 01Introduction
  2. 02Methods
  3. 03Cases (Summarized in Table 1)
  4. 04Discussion
  5. 05Conclusion
  6. 06CRediT authorship contribution statement
  7. 07Ethics declaration
  8. 08Declaration of Competing Interest
Text size
Work overview

Section 7 of 8

Ethics declaration

Latefah Aleshaiwi, Afrah Alotaibi, Mohsen Alzahrani, Mohammad Bosaeed, Hajar AlQahtani, and Abdulellah Almohaya · about 1 minutes

Original source ↗

The authors have NOT obtained informed consent from participants or their legal representatives. Because no identifiable information was used. As per the IRB approval, Explicit authorization/consent from the patient must be sought for the use of identifiable information.

This study was performed in compliance with relevant laws, regulatory frameworks and guidelines where the research took place. This study was approved by the the King Abdullah International Medical Research Center (Approval No. 342026/ NRR26/036/5).

This research follows the CARE guidelines and the CARE checklist.